Johanna Kuhlin

Publications
CV
Public outreach and news

Articles

Article: CLINICAL INFECTIOUS DISEASES. 2021;73(9):e3511-e3517

Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuberculosis

Kuhlin J; Forsman LD; Mansjo M; Nordvall MJ; Wijkander M; Wagrell C; Jonsson J; Groenheit R; Werngren J; Schon T; Bruchfeld J
Article: EUROPEAN RESPIRATORY JOURNAL. 2021;57(3):2003463

Suboptimal moxifloxacin and levofloxacin drug exposure during treatment of patients with multidrug-resistant tuberculosis: results from a prospective study in China.

Davies Forsman L; Niward K; Kuhlin J; Zheng X; Zheng R; Ke R; Hong C; Werngren J; Paues J; Simonsson USH; Eliasson E; Hoffner S; Xu B; Alffenaar J-W; Schön T; Hu Y; Bruchfeld J
Article: JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2020;1158:122397

Development and validation of a simple LC-MS/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma

Zheng X; Jongedijk EM; Hu Y; Kuhlin J; Zheng R; Niward K; Paues J; Xu B; Forsman LD; Schon T; Bruchfeld J; Alffenaar J-WC
Article: LAKARTIDNINGEN. 2020;117:20039

[Is it time to use sputum induction as a complementary specimen collection procedure in adult patients with suspected pulmonary tuberculosis?].

Kuhlin J; Tammelin A; Petersson J; Chryssanthou E; Tideholm-Nylén A; Schön T; Bruchfeld J
Article: BMJ OPEN. 2020;10(6):e035350

Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study

van den Elsen SHJ; Sturkenboom MGG; Akkerman O; Barkane L; Bruchfeld J; Eather G; Heysell SK; Hurevich H; Kuksa L; Kunst H; Kuhlin J; Manika K; Moschos C; Mpagama SG; Munoz Torrico M; Skrahina A; Sotgiu G; Tadolini M; Tiberi S; Volpato F; van der Werf TS; Wilson MR; Zuniga J; Touw DJ; Migliori GB; Alffenaar J-W
Article: BMJ OPEN. 2018;8(9):e023899

Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study

Forsman LD; Niward K; Hu Y; Zheng R; Zheng X; Ke R; Cai W; Hong C; Li Y; Gao Y; Werngren J; Paues J; Kuhlin J; Simonsson USH; Eliasson E; Alffenaar J-W; Mansjo M; Hoffner S; Xu B; Schon T; Bruchfeld J
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2018;22(5):544-550

Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

Kuhlin J; Smith C; Khaemraev A; Tigay Z; Parpieva N; Tillyashaykhov M; Achar J; Hajek J; Greig J; du Cros P; Moore D

All other publications

Review: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023;62(3):106914

Is there a need to optimise pyrazinamide doses in patients with tuberculosis? A systematic review

Chen RH; Michael T; Kuhlin J; Schon T; Stocker S; Alffenaar J-WC
Thesis / dissertation: 2023

Treatment optimisation of multidrug-resistant tuberculosis

Kuhlin, Johanna
Corrigendum: JOURNAL OF MASS SPECTROMETRY AND ADVANCES IN THE CLINICAL LAB. 2022;25:72

Corrigendum to "Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs" [Clin. Mass Spectrom. 14(Part A) (2019) 34-45]

Kuhlin J; Sturkenboom MGG; Ghimire S; Margineanu I; Van den Elsen SHJ; Simbar N; Akkerman OW; Jongedijk EM; Koster RA; Bruchfeld J; Touw DJ; Alffenaar J-WC
Review: CLINICAL MASS SPECTROMETRY. 2019;14:34-45

Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs

Kuhlin J; Sturkenboom MGG; Ghimire S; Margineanu I; van den Elsen SHJ; Simbar N; Akkerman OW; Jongedijk EM; Koster RA; Bruchfeld J; Touw DJ; Alffenaar J-WC

Employments

Affiliated to Research, Department of Medicine, Karolinska Institutet, 2022-2025

Degrees and Education

Doctor Of Philosophy, Department of Medicine, Solna, Karolinska Institutet, 2023
Degree Of Doctor Of Philosophy, Department of Medicine, Solna, Karolinska Institutet, 2023

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI